Schedule 13G
IDYA Schedule 13G filing by Capital Research Global Investors
Capital Research Global Investors reported beneficial ownership of 87.6M shares, representing 12% of IDEAYA Biosciences, Inc. in this filing.
FiledAug 13, 2025
Ownership dateJun 30, 2025
Reported shares87.6M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
6.6M
Shared voting power
6.6M
Sole dispositive power
6.6M
Shared dispositive power
6.6M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$24.42as of Aug 13, 2025
Latest tracked price$36.04as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Capital Research Global Investors
- CIK
- CIK0001422848
- Accession
- 0001422848-25-000172
- Form
- Schedule 13G
Read the filing in context